Phase 3 Readout~month
Phase 3 Topline: A Multicenter, Randomised, Comparative, Open-label Phase III Aiming to Compare the Survival of Patie
- Company
- AGENUS INC (AGEN)
- Drug
- Folfox Protocol
- Indication
- Gastric Cancer; MSI-H; Metastatic Cancer
Other upcoming events for AGEN
Phase 3 ReadoutPhase 3 Topline: Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Col
Phase 3 ReadoutPhase 3 Topline: Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combin
Patent ExpiryPatent/Exclusivity Expiry: POSLUMA
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.